# Combined Qigong and Acupressure for Improving Chemotherapy-induced Peripheral Neuropathy

> **NCT05764447** · NA · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 110 (actual)

## Conditions studied

- Cancer
- Chemotherapy-induced Peripheral Neuropathy

## Interventions

- **BEHAVIORAL:** Combined qigong Baduanjin and self-administered acupressure
- **BEHAVIORAL:** Wait-list Control

## Key facts

- **NCT ID:** NCT05764447
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-10
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764447, "Combined Qigong and Acupressure for Improving Chemotherapy-induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05764447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*